Aggravated pneumonia and diabetes in SARS-CoV-2 infected diabetic mice

References

• WHO COVID-19 Dashboard. Geneva: World Health Organization, 2020. Available online: https://covid19.who.int/.
   Google Scholar
• Lin P, Wang M, Wei Y, et al. Coronavirus in human diseases: mechanisms and advances in clinical treatment. MedComm. 2020;1(3):270–301.
   PubMedGoogle Scholar
• Wang M-Y, Zhao R, Gao L-J, et al. SARS-CoV-2: structure, biology, and structure-based therapeutics development. Front Cell Infect Microbiol. 2020;10:587269.
   PubMed Web of Science ®Google Scholar
• Gao Y-D, Ding M, Dong X, et al. Risk factors for severe and critically ill COVID-19 patients: a review. Allergy. 2021;76(2):428–455.
   PubMed Web of Science ®Google Scholar
• Lui GC-Y, Yip TC-F, Wong VW-S, et al. Significantly lower case-fatality ratio of coronavirus disease 2019 (COVID-19) than severe acute respiratory syndrome (SARS) in Hong Kong – a territory-wide cohort study. Clin Infect Dis. 2021;72(10):e466–e475.
   PubMed Web of Science ®Google Scholar
• Barron E, Bakhai C, Kar P, et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol. 2020;8(10):813–822.
   PubMed Web of Science ®Google Scholar
• Yang JK, Feng Y, Yuan MY, et al. Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet Med. 2006;23(6):623–628.
   PubMed Web of Science ®Google Scholar
• Kulcsar KA, Coleman CM, Beck SE, et al. Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection. JCI Insight. 2019;4:20.
   Web of Science ®Google Scholar
• Kazakou P, Lambadiari V, Ikonomidis I, et al. Diabetes and COVID-19; A bidirectional interplay. Front Endocrinol. 2022;13:780663.
   PubMed Web of Science ®Google Scholar
• Hamming I, Timens W, Bulthuis MLC, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631–637.
   PubMed Web of Science ®Google Scholar
• Rubino F, Amiel SA, Zimmet P, et al. New-onset diabetes in Covid-19. N Engl J Med. 2020;383(8):789–790.
   PubMed Web of Science ®Google Scholar
• Kazakou P, Paschou SA, Psaltopoulou T, et al. Early and late endocrine complications of COVID-19. Endocr Connect. 2021;10(9):R229–R239.
   PubMed Web of Science ®Google Scholar
• Federation ID. IDF Diabetes Atlas 2022 [cited 2022 6/7]. Available from: https://diabetesatlas.org/
   Google Scholar
• D'Souza AM, Neumann UH, Glavas MM, et al. The glucoregulatory actions of leptin. Mol Metab. 2017;6(9):1052–1065.
   PubMed Web of Science ®Google Scholar
• Suriano F, Vieira-Silva S, Falony G, et al. Novel insights into the genetically obese (ob/ob) and diabetic (db/db) mice: two sides of the same coin. Microbiome. 2021;9(1):147.
   PubMed Web of Science ®Google Scholar
• Puls M, Beuthner BE, Topci R, et al. Impact of myocardial fibrosis on left ventricular remodelling, recovery, and outcome after transcatheter aortic valve implantation in different haemodynamic subtypes of severe aortic stenosis [马松染色aipathwell]. Eur Heart J. 2020;41(20):1903–1914.
   PubMed Web of Science ®Google Scholar
• Yang J, Yan Y, Zhong W. Application of omics technology to combat the COVID-19 pandemic. MedComm. 2021;2(3):381–401.
   PubMedGoogle Scholar
• Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. 2021 Jan;93(1):250–256.
   PubMed Web of Science ®Google Scholar
• Taha M, Sharma A, Soubani A. Clinical deterioration during neutropenia recovery after G-CSF therapy in patient with COVID-19. Respir Med Case Rep. 2020;31:101231–101231.
   PubMed Web of Science ®Google Scholar
• Lazarus HM. Gale RPG-CSF are different GM-CSF which one is better for COVID-19? Acta Haematol. 2021;144(4):355–359.
   PubMed Web of Science ®Google Scholar
• Lazarus HM, Gale RP. Is G-CSF dangerous in COVID-19: why not use GM-CSF? Acta Haematol. 2021;144(3):350–351.
   PubMed Web of Science ®Google Scholar
• Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, et al. SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020;54:62–75.
   PubMed Web of Science ®Google Scholar
• Komastu T, Ireland DD, Reiss CS. IL-12 and viral infections. Cytokine Growth Factor Rev. 1998;9(3-4):277–285.
   PubMed Web of Science ®Google Scholar
• Pala D, Pistis M. Anti-IL5 drugs in COVID-19 patients: role of eosinophils in SARS-CoV-2-induced immunopathology. Front Pharmacol. 2021;12:622554.
   PubMed Web of Science ®Google Scholar
• Corkey BE. Banting lecture 2011: hyperinsulinemia: cause or consequence? Diabetes. 2012;61(1):4–13.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–419.
   PubMed Web of Science ®Google Scholar
• Yarmolinsky J, Bordin Barbieri N, Weinmann T, et al. Plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis of observational studies. Sci Rep. 2016;6:17714–17714.
   PubMed Web of Science ®Google Scholar
• Lyon CJ, Hsueh WA. Effect of plasminogen activator inhibitor-1 in diabetes mellitus and cardiovascular disease. Am J Med. 2003;115(Suppl. 8A):62S–68S.
   PubMedGoogle Scholar
• Bhattacharya S, Dunn P, Thomas CG, et al. Immport, toward repurposing of open access immunological assay data for translational and clinical research. Sci Data. 2018;5:180015.
   PubMed Web of Science ®Google Scholar
• Bindea G, Mlecnik B, Hackl H, et al. ClueGO: a cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009;25(8):1091–1093.
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504.
   PubMed Web of Science ®Google Scholar
• Chen L, Guo L, Tian J, et al. Overexpression of CXC chemokine ligand 14 exacerbates collagen-induced arthritis. J Immunol. 2010;184(8):4455–4459.
   PubMed Web of Science ®Google Scholar
• Rapp M, Wintergerst MWM, Kunz WG, et al. CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes. J Exp Med. 2019;216(5):1170–1181.
   PubMed Web of Science ®Google Scholar
• Yoshida H, Miyazaki Y. Interleukin 27 signaling pathways in regulation of immune and autoimmune responses. Int J Biochem Cell Biol. 2008;40(11):2379–2383.
   PubMed Web of Science ®Google Scholar
• Naderi A, Farmaki E, Chavez B, et al. Beneficial effects of CCL8 inhibition at lipopolysaccharide-induced lung injury. iScience. 2022;25(12):105520.
   PubMed Web of Science ®Google Scholar
• Mor A, Segal Salto M, Katav A, et al. Blockade of CCL24 with a monoclonal antibody ameliorates experimental dermal and pulmonary fibrosis. Ann Rheum Dis. 2019;78(9):1260–1268.
   PubMed Web of Science ®Google Scholar
• Du L, Xu C, Shi J, et al. Elevated CXCL14 in induced sputum was associated with eosinophilic inflammation and airway obstruction in patients with asthma. Int Arch Allergy Immunol. 2022;183(11):1216–1225.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.
   PubMed Web of Science ®Google Scholar
• Snel B, Lehmann G, Bork P, et al. STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene. Nucleic Acids Res. 2000;28(18):3442–3444.
   PubMed Web of Science ®Google Scholar
• Chin C-H, Chen S-H, Wu H-H, et al. Cytohubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(Suppl. 4):S11.
   PubMed Web of Science ®Google Scholar
• Bradley KH, McConnell SD, Crystal RG. Lung collagen composition and synthesis: characterization and changes with age. J Biol Chem. 1974;249(9):2674–2683.
   PubMed Web of Science ®Google Scholar
• Mereness JA, Bhattacharya S, Ren Y, et al. Collagen VI deficiency results in structural abnormalities in the mouse lung. Am J Pathol. 2020 Feb;190(2):426–441.
   PubMed Web of Science ®Google Scholar
• Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care. 2003 Feb;26(2):510–513.
   PubMed Web of Science ®Google Scholar
• Ma CM, Yin FZ. The mortality in infectious inpatients with type 2 diabetes compared with non-diabetic population: infection in type 2 diabetes. Medicine. 2019 Jun;98(24):e16025.
   PubMed Web of Science ®Google Scholar
• Belikina DV, Malysheva ES, Petrov AV, et al. COVID-19 in patients with diabetes: clinical course, metabolic status, inflammation, and coagulation disorder. Sovrem Tekhnol Med. 2021;12(5):6–16.
   PubMed Web of Science ®Google Scholar
• Guan W-J, Ni Z-Y, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen J, Gong X, et al. Clinical characteristics and outcomes of type 2 diabetes patients infected with COVID-19: a retrospective study. Engineering. 2020;6(10):1170–1177.
   Web of Science ®Google Scholar
• Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar;579(7798):270–273.
   PubMed Web of Science ®Google Scholar
• Ren W, Zhu Y, Wang Y, et al. Comparative analysis reveals the species-specific genetic determinants of ACE2 required for SARS-CoV-2 entry. PLoS Pathog. 2021 Mar;17(3):e1009392.
   PubMed Web of Science ®Google Scholar
• Shuai H, Chan JF, Yuen TT, et al. Emerging SARS-CoV-2 variants expand species tropism to murines. EBioMedicine. 2021 Nov;73:103643.
   PubMed Web of Science ®Google Scholar
• Hu J, Hu Y, Hertzmark E, et al. Weight change, lifestyle, and mortality in patients with type 2 diabetes. J Clin Endocrinol Metab. 2022;107(3):627–637.
   PubMed Web of Science ®Google Scholar
• Tsai TC, Lee CH, Cheng BC, et al. Body mass index-mortality relationship in severe hypoglycemic patients with type 2 diabetes. Am J Med Sci. 2015 Mar;349(3):192–198.
   PubMed Web of Science ®Google Scholar
• Vaillant MF, Agier L, Martineau C, et al. Food intake and weight loss of surviving inpatients in the course of COVID-19 infection: a longitudinal study of the multicenter NutriCoviD30 cohort. Nutrition. 2022 Jan;93:111433.
   PubMed Web of Science ®Google Scholar
• Allard N, Maruani A, Cret C, et al. Acute hypothermia in Covid 19: a case report. eNeurol Sci. 2020 Sep;20:100248.
   Google Scholar
• Herder V, Dee K, Wojtus JK, et al. Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defenses. PLoS Biol. 2021;19(12):e3001065.
   PubMed Web of Science ®Google Scholar
• Zheng S, Fan J, Yu F, et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ. 2020;369:m1443.
   PubMed Web of Science ®Google Scholar
• Liu Y, Yang Y, Zhang C, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63(3):364–374.
   PubMed Web of Science ®Google Scholar
• Nakamura H, Weiss ST, Israel E, et al. Eotaxin and impaired lung function in asthma. Am J Respir Crit Care Med. 1999;160(6):1952–1956.
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang J, Liu C, et al. IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19. Mol Med. 2020;26(1):97–97.
   PubMed Web of Science ®Google Scholar
• Logette E, Lorin C, Favreau C, et al. A machine-generated view of the role of blood glucose levels in the severity of COVID-19. Front Public Health. 2021;9:695139.
   PubMed Web of Science ®Google Scholar
• Lecube A, Pachón G, Petriz J, et al. Phagocytic activity is impaired in type 2 diabetes mellitus and increases after metabolic improvement. PLoS One. 2011;6(8):e23366.
   PubMed Web of Science ®Google Scholar
• McManus LM, Bloodworth RC, Prihoda TJ, et al. Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia. J Leukoc Biol. 2001 Sep;70(3):395–404.
   PubMed Web of Science ®Google Scholar
• Montefusco L, Ben Nasr M, D'Addio F, et al. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat Metab. 2021;3(6):774–785.
   PubMedGoogle Scholar
• Hayden MR. An immediate and long-term complication of COVID-19 may be type 2 diabetes mellitus: the central role of β-cell dysfunction, apoptosis and exploration of possible mechanisms. Cells. 2020;9:11.
   Web of Science ®Google Scholar